309.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$315.53
Offen:
$312.35
24-Stunden-Volumen:
868.81K
Relative Volume:
1.30
Marktkapitalisierung:
$25.36B
Einnahmen:
$14.14B
Nettoeinkommen (Verlust:
$942.70M
KGV:
27.41
EPS:
11.2856
Netto-Cashflow:
$1.38B
1W Leistung:
+4.22%
1M Leistung:
+10.46%
6M Leistung:
+13.91%
1J Leistung:
+18.92%
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
309.30 | 24.70B | 14.14B | 942.70M | 1.38B | 11.29 |
|
TMO
Thermo Fisher Scientific Inc
|
574.38 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
195.02 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
559.07 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
|
IQV
Iqvia Holdings Inc
|
235.07 | 35.59B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
A
Agilent Technologies Inc
|
138.37 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
LH|Labcorp Holdings Inc|Price:301.225|Chg%:+4.455 - TradingKey
Labcorp Holdings Inc (LH) Income Statement - TradingKey
Labcorp Holdings Inc (LH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Labcorp Holdings Inc (LH) Balance Sheet - TradingKey
Labcorp Launches Marker Genetic Health Panel (LH) to Enhance Ris - GuruFocus
Labcorp launches genetic health panel for consumers - Investing.com
Labcorp launches genetic health panel for consumers By Investing.com - Investing.com Canada
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing - marketscreener.com
Labcorp's New Test Pairs Inherited-Risk Results With Counselor Support - Stock Titan
Labcorp Holdings Inc. (LH) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc (LH) Institutional Confidence - TradingKey
Will Analyst Upgrades and ColoSense Momentum Change Labcorp Holdings' (LH) Narrative - Sahm
Labcorp Holdings Inc (LH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LH|Labcorp Holdings Inc|Price:296.770|Chg%:+5.840 - TradingKey
Labcorp Holdings (LH) Q1 2026 Earnings Call Transcript - Fortune
Labcorp Holdings Inc. (LH) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued? - Yahoo Finance
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. (LH) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors? - Yahoo Finance
Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength? - Yahoo Finance
Labcorp Holdings Inc (LH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
A Look at Labcorp Holdings Inc (LH) After 3.4% Gain -- GF Value $272.67 vs Price $291.02 - GuruFocus
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why Labcorp Holdings (LH) Stock Is Up Today - Moomoo
Labcorp Holdings Inc stock hits 52-week high at 293.92 USD - Investing.com
Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
BR:L1CA34 Stock Latest News - TipRanks
Labcorp (LH) Secures $364.7M Contract for Military Health Services - GuruFocus
Labcorp Holdings Inc. (LH) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (LH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Prepares to Report Q2 Earnings: What's in the Cards? - TradingView
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - GlobeNewswire Inc.
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Labcorp Holdings Inc. (LH): Investor Outlook With A 10% Upside Potential - DirectorsTalk Interviews
Labcorp Holdings Inc. (N6B) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc. (N6B) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Labcorp Holdings Inc (LH) Stock Up 3.7% but GF Value Says Overva - GuruFocus
Labcorp To Pay $14.5M To Settle Medicare Fraud Allegations Over Unnecessary Drug Testing - Yahoo Finance
Diagnostics Co. Labcorp Settles FCA Claims For $14.5M - Law360
Labcorp seen as a steady growth buy with cost c... - Pluang
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Labcorp Holdings Inc-Aktie (LH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Vaughn Bryan T | EVP and President, Diagnostics |
Jul 02 '26 |
Sale |
286.19 |
234 |
66,968 |
6,746 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):